Joint laxity, familial
disease diseaseOn this page
Also known as EDS 11 (formerly)EDS XIEDS11Ehlers-Danlos syndrome type 11, formerlyEhlers-Danlos syndrome, type 11 (formerly)familial joint instability syndromefamilial joint laxityJoint instability syndrome
Summary
Joint laxity, familial (MONDO:0007842) is a disease and 1 clinical trial. A subtype of Ehlers-Danlos syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- Phenotypes (HPO): 8
- Clinical trials: 1
Clinical features
Signs & symptoms
Clinical features (HPO)
8 HPO clinical features (Orphanet curated; top 8 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001382 | Joint hypermobility | Very frequent (80-99%) |
| HP:0001374 | Congenital hip dislocation | Very frequent (80-99%) |
| HP:0002999 | Patellar dislocation | Very frequent (80-99%) |
| HP:0002815 | Abnormality of the knee | Frequent (30-79%) |
| HP:0000023 | Inguinal hernia | Occasional (5-29%) |
| HP:0002823 | Abnormality of femur morphology | Occasional (5-29%) |
| HP:0003834 | Shoulder dislocation | Occasional (5-29%) |
| HP:0009811 | Abnormality of the elbow | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | joint laxity, familial |
| Mondo ID | MONDO:0007842 |
| MeSH | C535884 |
| OMIM | 147900 |
| Orphanet | 2295 |
| SNOMED CT | 71322004 |
| UMLS | C0268349 |
| MedGen | 120629 |
| GARD | 0003054 |
| Is cancer (heuristic) | no |
Also known as: EDS 11 (formerly) · EDS XI · EDS11 · Ehlers-Danlos syndrome type 11, formerly · Ehlers-Danlos syndrome, type 11 (formerly) · familial joint instability syndrome · familial joint laxity · Joint instability syndrome · joint laxity, familial
Disease family
This is a subtype of Ehlers-Danlos syndrome. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › syndromic disease › Ehlers-Danlos syndrome › joint laxity, familial
Related subtypes (24): Ehlers-Danlos syndrome, classic type, Ehlers-Danlos syndrome, hypermobility type, Ehlers-Danlos syndrome, arthrochalasia type, Ehlers-Danlos syndrome, spondylodysplastic type, Ehlers-Danlos syndrome, periodontitis type, Ehlers-Danlos syndrome, autosomal dominant, type unspecified, Ehlers-Danlos syndrome, fibronectinemic type, Ehlers-Danlos syndrome, dermatosparaxis type, brittle cornea syndrome, X-linked Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome, Beasley-Cohen type, Ehlers-Danlos syndrome, kyphoscoliotic type, 2, Ehlers-Danlos syndrome, kyphoscoliotic type 1, Ehlers-Danlos syndrome, vascular-like type, Ehlers-Danlos/osteogenesis imperfecta syndrome, Ehlers-Danlos syndrome, vascular type, spondylodysplastic Ehlers-Danlos syndrome, Bethlem myopathy 2, Ehlers-Danlos syndrome, classic-like, 2, COL1A1-related Ehlers-Danlos syndrome, COL1A2-related Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, classic-like, 3
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02725333 | Not specified | COMPLETED | Does Shoulder Stabilizations Stabilize Shoulders? |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.